3[1]Robert W.Mcmurray,Kenneth J.Hardy.Cox-2 inhibitors:today and tomorrow[J].Am J Med Sci 2002,323(4):181-189.
4[2]Bombardier C,Laine L,Reicin A,etal.Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis:VIGOR Study Group[J].N Engl J Med 2000,343(21):1520-1528.
5[3]Silverstein FE,Faich G,Goldstein JL,et al.Gastrointestinal toxicity with celecoxib vs NSAIDs for osteoarthritis and rheumatoid arthritis:the CLASS study:a randomized controlled trial:Celecoxib Long-term Arthritis Safety Study[J].JAMA 2000,284(10):1247-1255.
6[5]Laurence G.Howes,Henry Krum.Selective Cyclooxygenase-2 inhibitors and myocardial infarction[J].Drug safety,2002,25(12):829-835.
7[6]Matthew R.,Rhoda S.S.,Alise R.,Selective COX-2 inhibition and cardiovascular effects:a review of the rofecoxib development program[J].Am.Heart J.2003,146:591-604.
8[8]D.Craig Brater.Renal effects of cyclooxygyenase-2-selective inhibitors[J].J Pain Symptom Manage.2002,23:S15-20.
9[9]Suzanne.K,Swan,David W.Rudy.Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet[J].ANN intern Med.2000,133:1-9.
10[10]Syed R.Ahmad,Cindy Kortepeter,Allen Brinker,Renal failure associated with the use of celecoxib and rofecoxib[J].Drug safety.2002,25(7):537-544.
7Reuben SS,Ekman EF,Raghunathan K,et al.The effect of cyclooxygenase-2 inhibition on acute and chronic donor-site pain after spinal-fusion surgery[J].Reg Anesth Pain Med,2006,31(1):6-13.
8Cui JG,Kuroda H,Chandrasekharan NV, et al.Cyclooxygenase-3 gene expression in Alzheimer hippocampus and in stressed human neural cells[J].Neurochem Res,2004,29(9):1731-1737.
9Straube S,Derry S,McQuay HJ,et al.Effect of preoperative Cox- II-selective NSAIDs (coxibs) on postoperative outcomes: a systematic review of randomized studies[J].Acta Anaesthesiol Seand,2005,49(5):601-613.
10Philip BK,Reese PR,Burch SP.The economic impact of opioids on Postoperative pain management[J].J Clin Anesth,2002,14(5):354-364.
